Abstract
The 1997 Bovine Spongiform Encephalopathy enquiry and the 2001 Hepatitis C litigation judgement set the UK scene for evoking the precautionary principle and the legal precedent that liability for defective transfusion products should not be dependent on medical negligence, but on the mere fact of defectiveness. Animal models indicate that vCJD in humans, with infection via the oral route, is likely to be associated with infectivity within the lymphoreticular system (LRS). This is likely to appear prior to the involvement of the central nervous system and thus infectivity is likely to be present in the LRS before the onset of clinical disease. A number of relevant epidemiological studies using LRS tissue have shown a low, but measurable, existence of the carrier state in vCJD. Two possible cases of transmission of the abnormal prion of vCJD by blood transfusion suggested that tissues might also transmit and that testing of LRS tissue from deceased potential tissue donors should be considered as a first measure towards the prevention of vCJD transmission by tissues designated for use in transplantation. A variety of different tissues could be used as representative of the LRS, but each is associated with problems of feasibility and practicality. Assays for vCJD have not been validated in the context of donor screening rather than epidemiological studies nor on deceased donors. However, given the number of vCJD cases in the UK, significant attention should be paid to the logistical, ethical, social and other issues associated with undertaking vCJD testing of tissue donors, with a view to introducing testing of deceased tissue donors for vCJD disease or latency.
Similar content being viewed by others
References
A v National Blood Authority 2001. TNLR No 200 (QB Div) (QL) (Burton J).
BSE Inquiry Report 2000. www.bseinquiry.gov.uk.
M.E. Bruce I. McConnell R.G. Will J.W. Ironside (2001) ArticleTitleDetection of variant Creutzfeldt Jacob disease infectivity in extraneural tissues Lancet 358 208–209 Occurrence Handle10.1016/S0140-6736(01)05411-3 Occurrence Handle11476840 Occurrence Handle1:STN:280:DC%2BD3MvivV2iuw%3D%3D
InstitutionalAuthorNameCentres for Disease Control (1987a) ArticleTitleRapidly progressive dementia in a patient who received a cadaveric dura mater graft MMWR 36 IssueID4 49–55
InstitutionalAuthorNameCentres for Disease Control (1987b) ArticleTitleUpdate: Creutzfeldt-Jakob disease in a patient receiving a cadaveric dura mater graft MMWR 36 IssueID21 324–325
InstitutionalAuthorNameCentres for Disease Control (1989) ArticleTitleUpdate: Creutzfeldt-Jakob disease in a second patient who received a cadaveric dura mater graft MMWR 38 IssueID3 37–43
InstitutionalAuthorNameCentres for Disease Control (1993) ArticleTitleCreutzfeldt-Jakob disease in patients who received a cadaveric dura mater graft MMWR 42 IssueID28 560–563
Clarke P. and Ghani A.C. 2005. Projections of the future course of the primary vCJD epidemic in the UK: Inclusion of subclinical infection and the possibility of wider genetic susceptibility. J. Roy. Soc. Interface doi:10.1098/rsif.2004.0017 (published on line).
Clinical Incidents Panel 2001. The management of possible exposure to CJD through medical procedures: A Consultation Paper.pp 14.2www.dh.gov.uk/assetRoot/04/07/82/21/04078221.pdf.
Council of Europe 2002. Guide to Safety and Quality Assurance for Organs, Tissues and Cells.
Department of Health. Quarterly analysis of the incidence of vCJDwebsite www.dh.gov.uk.
P. Duffy J. Wolf G. Collins A.G. Devoe B. Steeten D. Cowen (1974) ArticleTitlePossible person to person transmission of Creutzfeldt-Jakob disease New Engl. J. Med. 290 692–693 Occurrence Handle4591849 Occurrence Handle1:STN:280:DyaE2c7gtlGisg%3D%3D
`Guidelines for tissue bankingȁ9 in UK Blood Transfusion and Tissue Transplantation Guidelines.2002. Sixth Edition. The Stationary OfficeLondon.Available at http://www.transfusionguidelines.org.uk.
A.F. Hill R.J. Butterworth S. Joiner G. Jackson M.N. Rossor D.J. Thomas A. Frosh N. Tolley J.E. Bell M. Spencer A. King S. Al-Sharraj J.W. Ironside P.L. Lantos J. Collinge (1999) ArticleTitleInvestigation of variant Creutzfeldt-Jacob disease and other human prion diseases with tonsil biopsy samples Lancet 353 IssueID9148 183–189 Occurrence Handle10.1016/S0140-6736(98)12075-5 Occurrence Handle9923873 Occurrence Handle1:STN:280:DyaK1M7itVOnug%3D%3D
D.A. Hilton E. Fathers P. Edwards J.W. Ironside J. Zajick (1998) ArticleTitlePrion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jacob disease Lancet 352 IssueID9129 703–704 Occurrence Handle10.1016/S0140-6736(98)24035-9 Occurrence Handle9728989 Occurrence Handle1:STN:280:DyaK1czpslajtA%3D%3D
D.A. Hilton A.L. Ghani L. Conyers P. Edwards L. McCardle D. Ritchie M. Penney D. Hegazy J.W. Ironside (2004) ArticleTitlePrevalence of lymphoreticular prion protein accumulation in UK tissue samples J. Pathol. 203 733–739 Occurrence Handle10.1002/path.1580 Occurrence Handle15221931 Occurrence Handle1:CAS:528:DC%2BD2cXmtFSmt7o%3D
J.W. Ironside D.A. Hilton A. Ghani N.J. Johnston L. Conyers L.M. McCardle D. Best (2000) ArticleTitleRetrospective study of prion-protein accumulation in tonsil and appendix tissues Lancet 355 1693–1694 Occurrence Handle10.1016/S0140-6736(00)02243-1 Occurrence Handle10905247 Occurrence Handle1:STN:280:DC%2BD3czmtFWrsA%3D%3D
P.G. Lindgren H. Hagberg B. Eriksson B. Glimelius A. Magnusson C. Sundstrom (1985) ArticleTitleExcision biopsy of the spleen by ultrasonic guidance Brit. J. Radiol. 58 IssueID693 853–857 Occurrence Handle3916062 Occurrence Handle1:STN:280:DyaL2s%2FltVGmsQ%3D%3D Occurrence Handle10.1259/0007-1285-58-693-853
C.A. Llewelyn P.E. Hewitt R.S. Knight K. Amar S. Clousens J. Mackenzie R.G. Will (2004) ArticleTitlePossible transmission of variant Creutzfeldt-Jakob disease by blood transfusion Lancet 363 417–421 Occurrence Handle10.1016/S0140-6736(04)15486-X Occurrence Handle14962520 Occurrence Handle1:STN:280:DC%2BD2c%2FnsVWhuw%3D%3D
E.E. Manuelidis J.N. Angelo E.J. Gorgacz J.H. Kim L. Manuelidis (1977) ArticleTitleExperimental Creutzfeldt-Jakob disease transmitted via the eye with infected cornea New Engl. J. Med. 296 IssueID23 1334–1336 Occurrence Handle323711 Occurrence Handle1:STN:280:DyaE2s7ntFSmsQ%3D%3D Occurrence Handle10.1056/NEJM197706092962308
Microbiological Safety of Blood Tissues for Transplantation, Department of Health: Guidance on the microbiological safety of human tissues and organs used in transplantation (NHS ExecutiveAugust 2000).
S. Muraca P. Chait B.L. Connolly K.M. Baskin M.J. Temple (2001) ArticleTitleUS-guided Core Biopsy of the Spleen in Children Radiology 218 200–206 Occurrence Handle11152802 Occurrence Handle1:STN:280:DC%2BD3MzitFCnsw%3D%3D
A.H. Peden M.W. Head D.L. Ritchie J.E. Bell J.W. Ironside (2004) ArticleTitlePreclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient Lancet 364 527–529 Occurrence Handle10.1016/S0140-6736(04)16811-6 Occurrence Handle15302196
S. Sundar T.K. Jha C.P. Thakur J. Engel H. Sindermann C. Fischer K. Junge A. Bryceson J. Berman (2002) ArticleTitleOral Miltefosine for Indian Visceral Leishmaniasis New Engl. J. Med. 347 IssueID22 1739–1746 Occurrence Handle10.1056/NEJMoa021556 Occurrence Handle12456849 Occurrence Handle1:CAS:528:DC%2BD38XpsV2js7c%3D
S.J. Tabrizi C.L. Elliott C. Weismann (2003) ArticleTitleEthical issues in human prion diseases Brit. Med. Bull. 66 305–316 Occurrence Handle14522867 Occurrence Handle1:STN:280:DC%2BD3svmtVakuw%3D%3D
R.A. Tange D. Troost M. Limburg (1990) ArticleTitleProgressive fatal dementia (Creutzfeldt-Jakob disease) in a patient who received homograft tissue for tympanic membrane closure Eur. Arch. Otorhinolaryngol. 247 199–201 Occurrence Handle10.1007/BF00178983 Occurrence Handle2198064 Occurrence Handle1:STN:280:DyaK3czivFalug%3D%3D
V. Thadani P.L. Penar J. Partington R. Kalb R. Janssen L.B. Schonberger C.S. Rabkin J.W. Prichard (1988) ArticleTitleCreutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft J. Neurosurg. 69 766–769 Occurrence Handle3054015 Occurrence Handle1:STN:280:DyaL1M%2Fjs1ersw%3D%3D
UK Blood Transfusion Tissue Transplantation Guidelines - vCJD Position Statement) http://www.transfusionguidelines.org.uk/docs/pdfs/position_statement_01_2005_02.pdf.
J.D.F. Wadsworth S. Joiner A.F. Hill T.A. Campbell M. Desbruslais P.J. Luthert J. Collinge (2001) ArticleTitleTissue distribution of protease resistant prion protein in variant Creutzfeldt Jakob disease using a highly sensitive immunoblotting assay Lancet 358 171–180 Occurrence Handle10.1016/S0140-6736(01)05403-4 Occurrence Handle11476832 Occurrence Handle1:CAS:528:DC%2BD3MXltlymsr4%3D
Warwick R. and Kearney J. 2004. Should tonsil be used as an analyte from cadaveric tissue donors to test for variant CJD? abstract, European Association for Tissue Banking EATB Prague.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Warwick, R., Eglin, R. Should Deceased Donors be Tested for vCJD?. Cell Tissue Banking 6, 263–270 (2005). https://doi.org/10.1007/s10561-005-1355-5
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10561-005-1355-5